Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02620800 |
| Title | Study of 5-fluorouracil (5-FU), Nab-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer |
| Acronym | FABLOx |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Celgene Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
| Tufts - New England Medical Center | Boston | Massachusetts | 02111 | United States | Details | |
| University of Michigan | Ann Arbor | Michigan | 48103 | United States | Details | |
| Karmanos Cancer Center Wayne State University | Detroit | Michigan | 48201 | United States | Details | |
| Cornell University Weill Medical College | New York | New York | 10065 | United States | Details | |
| Gibbs Cancer Center and Research Institute | Spartanburg | South Carolina | 29303 | United States | Details | |
| Virginia Mason Cancer Center | Seattle | Washington | 98101 | United States | Details |